Sarvesh Singh, the managing director of Alkem Laboratories, has made a landmark purchase by acquiring a sea-facing duplex in Bandra for a staggering ₹174 crore, marking one of the most significant ultra-luxury real estate deals in recent times.
Real EstateLuxury PropertyMumbaiAlkem LaboratoriesSarvesh SinghReal Estate MumbaiMay 01, 2025
The sea-facing duplex purchased by Sarvesh Singh is valued at ₹174 crore.
The duplex is located in the Bandra area of Mumbai, known for its prime residential properties and sea views.
Alkem Laboratories is a leading pharmaceutical company in India, known for its extensive range of products and significant market presence.
Bandra is highly desirable for luxury real estate due to its prime location, proximity to the sea, and the quality of life it offers, including high-end amenities and a well-established residential community.
This purchase reflects the strong demand for luxury real estate in Mumbai and the willingness of high-net-worth individuals to invest in premium properties, despite economic challenges.
Godrej Properties has purchased two group housing land parcels in Gurugram through an e-auction for a combined Rs 515 crore, with an estimated revenue potential of over Rs 3,400 crore.
Lemon Tree Hotels is set to open a new resort in Shirdi, Maharashtra, managed by Carnation Hotels, a subsidiary of the company. The property is expected to start operations in FY 2028, complementing the company's existing portfolio in the state.
Kolte-Patil Developers expects realisations to improve to ₹8
Co-working space provider India Accelerator has invested $4 million to expand its footprint by 2.5 lakh sq ft across Pune, Gurugram, and Noida.
Maharashtra's financial situation is precarious, warns Nitin Gadkari. The state's Ladki Bahna scheme may impact subsidy payments. Real estate investments in Dubai are on the rise among wealthy Indians.
Prestige Estates Projects Ltd faced significant setbacks in the first half of FY25, but is gearing up for a strong second half with major launches. Timely regulatory approvals will be crucial for the company to meet its ambitious targets.